{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:26:49Z","timestamp":1765888009444},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.2169\/internalmedicine.0405-17","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T22:25:28Z","timestamp":1528237528000},"page":"3093-3097","source":"Crossref","is-referenced-by-count":2,"title":["A Young Man with Non-alcoholic Steatohepatitis and Serum Anti-mitochondrial Antibody Positivity"],"prefix":"10.2169","volume":"57","author":[{"given":"Takuya","family":"Seike","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"},{"name":"System Biology, Graduate School of Advanced Preventive Medical Science, Kanazawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Komura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Omura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kumai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kagaya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, Kanazawa University Graduate School of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"System Biology, Graduate School of Advanced Preventive Medical Science, Kanazawa University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Unoura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219, 2003.","DOI":"10.1053\/jhep.2003.50193"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bedossa P. Histological assessment of NAFLD. Dig Dis Sci 61: 1348-1355, 2016.","DOI":"10.1007\/s10620-016-4062-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. European Association for the Study of the liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67: 145-172, 2017.","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ravi S, Shoreibah M, Raff E, et al. Autoimmune markers do not impact clinical presentation or natural history of steatohepatitis-related liver disease. Dig Dis Sci 60: 3788-3793, 2015.","DOI":"10.1007\/s10620-015-3795-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Loria P, Lonardo A, Leonardi F, et al. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 48: 2173-2181, 2003.","DOI":"10.1023\/B:DDAS.0000004522.36120.08"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Neuschwander-Tetri BA, Clark JM, Bass NM, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 52: 913-924, 2010.","DOI":"10.1002\/hep.23784"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Muratori P, Muratori L, Gershwin ME, et al.  'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol 135: 154-158, 2004.","DOI":"10.1111\/j.1365-2249.2004.02332.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Corpechot C, Chretien Y, Chazouilleres O, Poupon R. Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis. J Hepatol 53: 162-169, 2010.","DOI":"10.1016\/j.jhep.2010.02.019"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology 50: 291-308, 2009.","DOI":"10.1002\/hep.22906"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shibata M, Onozuka Y, Morizane T, et al. Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanazawa prefecture. J Gastroenterol 39: 255-259, 2004.","DOI":"10.1007\/s00535-003-1285-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cacoub P, Saadoun D, Bourliere M, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol 43: 764-770, 2005.","DOI":"10.1016\/j.jhep.2005.05.029"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li BA, Liu J, Hou J, et al. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations. World J Gastroenterol 21: 283-291, 2015.","DOI":"10.3748\/wjg.v21.i1.283"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ramos-Casals M, Pares A, Jara LJ, et al. Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature. J Viral Hepat 12: 648-654, 2005.","DOI":"10.1111\/j.1365-2893.2005.00642.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nezu S, Tanaka A, Yasui H, et al. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol 21: 1448-1454, 2006.","DOI":"10.1111\/j.1440-1746.2006.04434.x"},{"key":"15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","volume":"46","author":"PS Leung","year":"2007","unstructured":"15. Leung PS, Rossaro L, Davis PA, et al. Antimitochondrial antibodies in acute liver failure: implication for primary biliary cirrhosis. Hepatology 46: 1436-1442, 2007.","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bogdanos DP, Baum H, Grasso A, et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 40: 31-39, 2004.","DOI":"10.1016\/S0168-8278(03)00501-4"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Rinella ME. Nonalcoholic fatty liver disease. A systemic review. JAMA 313: 2263-2273, 2015.","DOI":"10.1001\/jama.2015.5370"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver disease, American college of gastroenterology, and the American gastroenterological association. Hepatology 55: 2005-2023, 2012.","DOI":"10.1002\/hep.25762"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ratziu V, de Ledinghen V, Oberti F, et al. A randomized controlled trial of high dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 54: 1011-1019, 2011.","DOI":"10.1016\/j.jhep.2010.08.030"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/21\/57_0405-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T05:19:28Z","timestamp":1541222368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/21\/57_0405-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":19,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0405-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}